{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:16:16Z","timestamp":1758892576421},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,23]]},"DOI":"10.7759\/cureus.60953","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:24:56Z","timestamp":1716510296000},"source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Embolism in Patients Admitted With Peripartum Cardiomyopathy: Prevalence, Predictors, and Associated In-Hospital Adverse Events"],"prefix":"10.7759","author":[{"given":"Omar","family":"Elkattawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey A","family":"Hamlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Dikdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysha","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Elkattawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Afriyie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afif","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius M","family":"Gardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2022.04.008","article-title":"Obstetric disorders and critical illness","volume":"43","author":"Griffin KM","year":"2022","unstructured":"Griffin KM, Oxford-Horrey C, Bourjeily G. Obstetric disorders and critical illness. Clin Chest Med. 2022, 43:471-88. 10.1016\/j.ccm.2022.04.008","journal-title":"Clin Chest Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany Z","year":"2016","unstructured":"Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016, 133:1397-409. 10.1161\/CIRCULATIONAHA.115.020491","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2015.01.004","article-title":"Molecular mechanisms of peripartum cardiomyopathy: a vascular\/hormonal hypothesis","volume":"25","author":"Bello NA","year":"2015","unstructured":"Bello NA, Arany Z. Molecular mechanisms of peripartum cardiomyopathy: a vascular\/hormonal hypothesis. Trends Cardiovasc Med. 2015, 25:499-504. 10.1016\/j.tcm.2015.01.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis MB","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:207-21. 10.1016\/j.jacc.2019.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10790","article-title":"Unveiling the mystery of peripartum cardiomyopathy: a traditional review","volume":"12","author":"Chinweuba GC","year":"2020","unstructured":"Chinweuba GC, Rutkofsky IH. Unveiling the mystery of peripartum cardiomyopathy: a traditional review. Cureus. 2020, 12:e10790. 10.7759\/cureus.10790","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00004","article-title":"Vasoinhibin, an N-terminal prolactin fragment, directly inhibits cardiac angiogenesis in three-dimensional heart culture","volume":"8","author":"Nakajima R","year":"2017","unstructured":"Nakajima R, Nakamura E, Harigaya T. Vasoinhibin, an N-terminal prolactin fragment, directly inhibits cardiac angiogenesis in three-dimensional heart culture. Front Endocrinol (Lausanne). 2017, 8:4. 10.3389\/fendo.2017.00004","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner D","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al.. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128:589-600. 10.1016\/j.cell.2006.12.036","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs J","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P, et al.. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019, 21:827-43. 10.1002\/ejhf.1493","journal-title":"Eur J Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, et al.. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016, 134:e579-646. 10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2019.05.03","article-title":"Detection and management of arrhythmias in peripartum cardiomyopathy","volume":"10","author":"Hoevelmann J","year":"2020","unstructured":"Hoevelmann J, H\u00e4hnle L, H\u00e4hnle J, Sliwa K, Viljoen C. Detection and management of arrhythmias in peripartum cardiomyopathy. Cardiovasc Diagn Ther. 2020, 10:325-35. 10.21037\/cdt.2019.05.03","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study","volume":"3","author":"Kolte D","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, et al.. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014, 3:e001056. 10.1161\/JAHA.114.001056","journal-title":"J Am Heart Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2016.02.008","article-title":"Characteristics and in-hospital outcomes of peripartum cardiomyopathy diagnosed during delivery in the United States from the Nationwide Inpatient Sample (NIS) database","volume":"22","author":"Afana M","year":"2016","unstructured":"Afana M, Brinjikji W, Kao D, et al.. Characteristics and in-hospital outcomes of peripartum cardiomyopathy diagnosed during delivery in the United States from the Nationwide Inpatient Sample (NIS) database. J Card Fail. 2016, 22:512-9. 10.1016\/j.cardfail.2016.02.008","journal-title":"J Card Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-1214","article-title":"Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders - results from the Japanese Nationwide survey of peripartum cardiomyopathy","volume":"75","author":"Kamiya CA","year":"2011","unstructured":"Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders - results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011, 75:1975-81. 10.1253\/circj.cj-10-1214","journal-title":"Circ J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-013-0366-9","article-title":"Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy","volume":"108","author":"Haghikia A","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E, et al.. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013, 108:366. 10.1007\/s00395-013-0366-9","journal-title":"Basic Res Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13412","article-title":"Perhexiline treatment improves toxic effects of \u03b2-adrenergic receptor stimulation in experimental peripartum cardiomyopathy","volume":"8","author":"Pfeffer TJ","year":"2021","unstructured":"Pfeffer TJ, List M, M\u00fcller JH, Scherr M, Bauersachs J, Hilfiker-Kleiner D, Ricke-Hoch M. Perhexiline treatment improves toxic effects of \u03b2-adrenergic receptor stimulation in experimental peripartum cardiomyopathy. ESC Heart Fail. 2021, 8:3375-81. 10.1002\/ehf2.13412","journal-title":"ESC Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw086","article-title":"Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy","volume":"38","author":"Stapel B","year":"2017","unstructured":"Stapel B, Kohlhaas M, Ricke-Hoch M, et al.. Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 2017, 38:349-61. 10.1093\/eurheartj\/ehw086","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255858-pulmonary-embolism-in-patients-admitted-with-peripartum-cardiomyopathy-prevalence-predictors-and-associated-in-hospital-adverse-events","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:25:00Z","timestamp":1716510300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255858-pulmonary-embolism-in-patients-admitted-with-peripartum-cardiomyopathy-prevalence-predictors-and-associated-in-hospital-adverse-events"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.60953","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}